<DOC>
	<DOC>NCT01491659</DOC>
	<brief_summary>It is hypothesized that Idoform plus will recuce the occurence of gastrointestinal side effects related to the use of antibiotics</brief_summary>
	<brief_title>A Study to Evaluate the Effect and Safety of Idoform Plus on Bowel Side Effects in Healthy Subjects Treated With Amoxicillin/ Clavulanate</brief_title>
	<detailed_description />
	<mesh_term>Diarrhea</mesh_term>
	<mesh_term>Clavulanic Acid</mesh_term>
	<mesh_term>Amoxicillin-Potassium Clavulanate Combination</mesh_term>
	<mesh_term>Clavulanic Acids</mesh_term>
	<mesh_term>Amoxicillin</mesh_term>
	<criteria>Healthy volunteers 1870 years of age Subjects with normal gastrointestinal function Subjects willing to provide written informed consent Subjects receiving antibiotic treatment within three months prior to inclusion in the study Pregnancy or planned pregnancy Breast feeding Subjects who are allergic to betalactam antibiotics, amoxicillin / clavulanate or its components Subjects with known renal insufficiency Subjects using products containing probiotics, fibers and/or prebiotics Subjects using proton pump inhibitors Subjects using H2 antagonists Subjects using antacids frequently</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2013</verification_date>
</DOC>